EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing

Seungchan An iD, Mei Zheng iD, In Guk Park iD, Leegu Song iD, Jino Kim, Minsoo Noh iD, Jong-Hyuk Sung

International Journal of Molecular Sciences · 08.07.2025 · 26 (14) · 6568

DOI: 10.3390/ijms26146568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2025. Verfasst von Seungchan An und 6 weiteren Autor:innen. Beteiligte Einrichtung: Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea. Hauptthemen laut MEDLINE: Androgens, Alopecia, Chemokine CXCL12, Fibroblasts. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Korean Fund for Regenerative Medicine, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgenetic alopecia (AGA) is a common form of hair loss characterized by androgen-driven tissue remodeling, including progressive follicular miniaturization and dermal fibrosis, which is accompanied by low-grade immune activation. However, the molecular mechanisms underlying this fibroimmune dysfunction remain poorly understood. Dermal fibroblasts (DFs) have been suggested as androgen-responsive stromal cells and a potential source of CXCL12, a chemokine implicated in fibroimmune pathology, but their precise role in AGA has not been fully established. In this study, we performed single-cell transcriptomic profiling of a testosterone-induced mouse model of AGA, with or without treatment of CXCL12-neutralizing antibody, to elucidate the pathological role of CXCL12 in mediating stromal-immune interactions. Our analysis suggested that DFs are the primary androgen-responsive population driving CXCL12 expression. Autocrine CXCL12-ACKR3 signaling in DFs activated TGF-β pathways and promoted fibrotic extracellular matrix deposition. In parallel, paracrine CXCL12-CXCR4 signaling reprogrammed Sox2+Twist1+ dermal papilla cells (DPCs) and promoted the accumulation of pro-fibrotic Trem2+ macrophages, contributing to impaired hair follicle regeneration. Notably, CXCL12 blockade attenuated these stromal and immune alterations, restored the regenerative capacity of DPCs, reduced pro-fibrotic macrophage infiltration, and promoted hair regrowth. Together, these findings identify CXCL12 as a central mediator of androgen-induced fibroimmune remodeling and highlight its potential as a therapeutic target in AGA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrogensAlopeciaChemokine CXCL12FibroblastsSkinSingle-Cell Gene Expression AnalysisSignal TransductionTransforming Growth Factor betaReceptors, CXCR4MacrophagesMice, Inbred C3HMaleAnimalsMiceSequence Analysis, RNAHair Follicle

Stichwörter der Autor:innen

CXCL12androgen receptorandrogenetic alopeciadermal fibrosissingle-cell RNA sequencingstromal-immune interaction

Substanzen

AndrogensCxcl12 protein, mouseChemokine CXCL12Transforming Growth Factor betaCXCR4 protein, mouseReceptors, CXCR4

Autor:innen und Institutionen

  • Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Epi Biotech Co., Ltd., Incheon 21984, Republic of Korea.
  • New Hair Plastic Surgery Clinic, Seoul 06134, Republic of Korea.

ORCID-Profile: Seungchan An, Mei Zheng, In Guk Park, Leegu Song, Minsoo Noh

Förderung

  • Korea Health Industry Development Institute
  • Korean Fund for Regenerative Medicine
  • National Research Foundation of Korea
  • Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Repu…
  • Korean Fund for Regenerative Medicine funded by the Ministry of Science and ICT and the Ministry of Health and Welfare, Republic of Korea
  • National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)

Zitieren

APA

An, S., Zheng, M., Park, I. G., Song, L., Kim, J., Noh, M., & Sung, J. H. (2025). CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing. International Journal of Molecular Sciences, 26(14), 6568. https://doi.org/10.3390/ijms26146568

Vancouver

An S, Zheng M, Park IG, Song L, Kim J, Noh M, et al. CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing. International Journal of Molecular Sciences. 2025;26(14):6568. doi:10.3390/ijms26146568

BibTeX
@article{An2025,
  author = {An, Seungchan and Zheng, Mei and Park, In Guk and Song, Leegu and Kim, Jino and Noh, Minsoo and Sung, Jong-Hyuk},
  title = {CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6568},
  doi = {10.3390/ijms26146568}
}
Kostenlos starten →